Should SGLT2 inhibitors be part of standard of care for patients with insufficiently controlled type 2 diabetes? (90 minutes Webinar)
- Zeh, P. (Chair)
Activity: Participating in or organising an event › Participation in workshop, seminar, course
Activity: Participating in or organising an event › Participation in workshop, seminar, course